Life Science Angels

AGED Diagnostics, led by founder Rachel Zayas-Schwartz just secured $2.2M in funding from the Central Texas Angel Network, Life Science Angels, and SWAN Impact Network to revolutionize liver disease detection. This investment will power AGED Diagnostics' next steps in bringing their blood test to market. Using targeted genomic sequencing, this test offers early, non-invasive detection for liver diseases like NASH and fibrosis, potentially sparing patients from more invasive biopsies and enabling faster, more effective interventions. As CTAN Deal Team member Anthony Gellert put it, AGED Diagnostics is filling a critical gap, giving healthcare providers the tools they need for earlier, life-changing decisions in liver care. We’re excited to support AGED Diagnostics as they work to make a real difference in liver disease detection and patient care. #healthcareinnovation #angelinvesting #CTAN #austintx #startups

MedTech Strategist is honored to welcome ATDev alongside CEO & Co-founder Todd Roberts as a Presenting Company at Innovation Summit San Diego 2024. Presenting in the Robotics and Orthopedic Rehabilitation Therapeutic Categories, ATDev (Orange, CA, USA) is a robotic medical device company spun out of UC Berkeley. They have developed a low-cost robotic device, Reflex, for rehabilitation of orthopedic injuries and surgeries. Welcome to #InnovationSanDiego, Todd and ATDev! 🤝 Climb the Summit to San Diego November 19-21, 2024: https://bit.ly/4gBjKW6 #robotics #medicaldevices #medtechinnovation #startups #roboticdevices #orthopedics Owen Kent Geoffrey M. Roche David Wilkinson Nick Dobrzelecki Bobby Xiong Tylor Langford Grace O'Connell, PhD Alain Millan

On Friday, Catherine Mohr is speaking at Fogarty Innovation in Mountain View. Catherine is a great speaker and her first TED speech on the future of #robotic surgery had a profound impact on me. I am excited about this event. Please feel free to comment or DM me if you are attending. https://lnkd.in/gb5tDVq2 Life Science Angels Peter A. Socarras Alperen OzalpMary G. Seo Yeon YoonPaola TorreLuc Ghislain

One the best aspects of attending the #MedTechConference2024 were the networking opportunities. 🤝 The conference has an app that allows attendees to schedule short meetings with each other (when it worked). I had the pleasure of connecting with entrepreneurs consultants, and angel investors - each conversation revealing new perspectives into the med tech world. But sometimes, it is the unplanned encounters that leave the biggest impact. One of my favorite surprises was bumping into Sandeep Makkar. We worked together at Ethicon, Inc. in Cincinnati before we both moved away to different parts of the world! #MTC2024 #MedTechFriends

This is a huge day for #MedTech as Ceribell │ AI-Powered Point-of-Care EEG ($CBLL) is set to #IPO this morning. If you haven't been counting, this is the first MedTech IPO in 3 years! There are some amazing dynamics to this financing: -Originally filed to raise $100 million and the bankers upsized it to $180 million due to demand -Offering range was $14 to $16 and it priced last night at $17. Let's see how the initial trading goes but hoping the high enthusiasm continues. What makes Ceribell special? -1H24 revenue of $30 million vs $20 million in 1H23 -Very high gross margins at 85% -Software as a service component to their revenue model -Belief amongst investors in their ability to continue scaling -AI? We are all rooting for Ceribell to crack the markets open and keep it that way for the deluge of MedTech IPOs to come! https://lnkd.in/e8kQynwa

Miss our recent webinar on smart financial moves for thriving startups? You're in luck. Watch the recording here: https://lnkd.in/e6K2H2Kb Thanks again to our partners Kymanox and Prendio